{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:27:27Z","timestamp":1793636847681,"version":"4.5.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K07804"],"award-info":[{"award-number":["21K07804"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K08304"],"award-info":[{"award-number":["19K08304"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K10935"],"award-info":[{"award-number":["24K10935"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.thromres.2026.109835","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:53:07Z","timestamp":1788969187000},"page":"109835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Transient suppression of fibrinolytic potential during cytokine release syndrome after chimeric antigen receptor T-cell therapy in B-cell malignancies"],"prefix":"10.1016","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1061-085X","authenticated-orcid":false,"given":"Takashi","family":"Ishihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9662-5093","authenticated-orcid":false,"given":"Yasuyuki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4803-9994","authenticated-orcid":false,"given":"Makiko","family":"Yamasaki-Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8886-6145","authenticated-orcid":false,"given":"Miki","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8473-0187","authenticated-orcid":false,"given":"Souichi","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2415-2194","authenticated-orcid":false,"given":"Keiji","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-4284","authenticated-orcid":false,"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.thromres.2026.109835_bb0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2026.109835_bb0010","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1634\/theoncologist.2019-0233","article-title":"The European Medicines Agency review of kymriah (tisagenlecleucel) for the treatment of acute lymphoblastic leukemia and diffuse large B-cell lymphoma","volume":"25","author":"Ali","year":"2020","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.thromres.2026.109835_bb0015","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00277-019-03685-z","article-title":"Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy","volume":"98","author":"Jiang","year":"2019","journal-title":"Ann. Hematol."},{"issue":"7","key":"10.1016\/j.thromres.2026.109835_bb0020","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1007\/s00277-025-06482-z","article-title":"Immunotherapy-associated hemostatic abnormalities: bleeding and thrombotic complications","volume":"104","author":"Li","year":"2025","journal-title":"Ann. Hematol."},{"issue":"14","key":"10.1016\/j.thromres.2026.109835_bb0025","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1182\/bloodadvances.2022007454","article-title":"Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma","volume":"6","author":"Yamasaki-Morita","year":"2022","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.thromres.2026.109835_bb0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1160\/TH13-04-0345","article-title":"Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis","volume":"110","author":"Matsumoto","year":"2013","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109835_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28016","article-title":"Disordered hemostasis associated with severely depressed fibrinolysis demonstrated using a simultaneous thrombin and plasmin generation assay during L-asparaginase induction therapy in pediatric acute lymphoblastic leukemia","volume":"67","author":"Ishihara","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"issue":"3","key":"10.1016\/j.thromres.2026.109835_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31524","article-title":"Hemostatic dynamics mainly based on hypofibrinolysis during early-phase interfant-type chemotherapy in three infants with acute lymphoblastic leukemia: results from Japan Children's Cancer Group ThrombALL-MLL-17","volume":"72","author":"Ishihara","year":"2025","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.thromres.2026.109835_bb0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12185-017-2213-5","article-title":"Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation","volume":"106","author":"Ishihara","year":"2017","journal-title":"Int. J. Hematol."},{"issue":"9","key":"10.1016\/j.thromres.2026.109835_bb0050","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/ped.13919","article-title":"Hemostatic function in hyperfibrinolytic disseminated intravascular coagulation","volume":"61","author":"Ishihara","year":"2019","journal-title":"Pediatr. Int."},{"issue":"2","key":"10.1016\/j.thromres.2026.109835_bb0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3324\/haematol.2019.229781","article-title":"Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)","volume":"105","author":"Yakoub-Agha","year":"2020","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.thromres.2026.109835_bb0060","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtct.2024.01.073","article-title":"Clinical impact of cytokine release syndrome on prolonged hematotoxicity after chimeric antigen receptor T cell therapy: KyoTox A-score, a novel prediction model","volume":"30","author":"Nakamura","year":"2024","journal-title":"Transplant Cell Ther."},{"issue":"4","key":"10.1016\/j.thromres.2026.109835_bb0065","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.thromres.2026.109835_bb0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/ped.13546","article-title":"Fibrinolytic abnormality associated with progression of pediatric solid tumor","volume":"60","author":"Ishihara","year":"2018","journal-title":"Pediatr. Int."},{"issue":"3","key":"10.1016\/j.thromres.2026.109835_bb0075","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"issue":"14","key":"10.1016\/j.thromres.2026.109835_bb0080","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1097\/CM9.0000000000002288","article-title":"Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy","volume":"135","author":"Mei","year":"2022","journal-title":"Chin. Med. J."},{"issue":"17","key":"10.1016\/j.thromres.2026.109835_bb0085","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/bloodadvances.2020002060","article-title":"Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma","volume":"4","author":"Hashmi","year":"2020","journal-title":"Blood Adv."},{"issue":"5","key":"10.1016\/j.thromres.2026.109835_bb0090","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.bbmt.2019.11.027","article-title":"Coagulation disorders after chimeric antigen receptor T cell therapy: analysis of 100 patients with relapsed and refractory hematologic malignancies","volume":"26","author":"Wang","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"21","key":"10.1016\/j.thromres.2026.109835_bb0095","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1182\/bloodadvances.2021004716","article-title":"Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy","volume":"5","author":"Johnsrud","year":"2021","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.thromres.2026.109835_bb0100","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1080\/10428194.2020.1852474","article-title":"Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma","volume":"62","author":"Parks","year":"2021","journal-title":"Leuk. Lymphoma"},{"issue":"6","key":"10.1016\/j.thromres.2026.109835_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005898","article-title":"CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity","volume":"11","author":"Jess","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.thromres.2026.109835_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/2052-0492-2-20","article-title":"Classifying types of disseminated intravascular coagulation: clinical and animal models","author":"Asakura","year":"2014","journal-title":"J. Intensive Care"},{"issue":"11","key":"10.1016\/j.thromres.2026.109835_bb0115","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/ped.14684","article-title":"Coagulation and fibrinolysis balance in disseminated intravascular coagulation","volume":"63","author":"Onishi","year":"2021","journal-title":"Pediatr. Int."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826002549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826002549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:46:00Z","timestamp":1793634360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826002549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":23,"alternative-id":["S0049384826002549"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109835","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transient suppression of fibrinolytic potential during cytokine release syndrome after chimeric antigen receptor T-cell therapy in B-cell malignancies","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109835"}}